Skip to main content
Consensus Study Report

VIEW LARGER COVER

Download Free PDF
Read Free Online
Buy Paperback:$65.00
Buy Ebook:$54.99

Nearly 20 million nuclear medicine procedures are carried out each year in the United States alone to diagnose and treat cancers, cardiovascular disease, and certain neurological disorders. Many of the advancements in nuclear medicine have been the result of research investments made during the past 50 years where these procedures are now a routine part of clinical care. Although nuclear medicine plays an important role in biomedical research and disease management, its promise is only beginning to be realized.

Advancing Nuclear Medicine Through Innovation highlights the exciting emerging opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. Health care and pharmaceutical professionals will be most interested in this book's examination of the challenges the field faces and its recommendations for ways to reduce these impediments.

RESOURCES AT A GLANCE

Topics

Suggested Citation

Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. https://doi.org/10.17226/11985.

Import this citation to:

Publication Info

173 pages | 6 x 9 | 

ISBNs: 
  • Paperback:  978-0-309-11067-9
  • Ebook:  978-0-309-13415-6
DOI: https://doi.org/10.17226/11985
Chapters skim
Front Matter i-xiv
Summary 1-9
1 Introduction 10-16
2 Nuclear Medicine 17-42
3 Nuclear Medicine Imaging in Diagnosis and Treatment 43-58
4 Targeted Radionuclide Therapy 59-74
5 Availability of Radionuclides for Nuclear Medicine Research 75-88
6 Radiotracer and Radiopharmaceutical Chemistry 89-103
7 Instrumentation and Computational Sciences 104-117
8 Education and Training of Nuclear Medicine Personnel 118-130
References 131-140
Appendix A Information-Gathering Sessions 141-145
Appendix B Glossary and Acronyms 146-150
Appendix C Commercially Available Radiopharmaceuticals 151-154
Appendix D Biographical Sketches Of Committee Members 155-159

What is skim?

The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.

Copyright Information

The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:

  • Republish text, tables, figures, or images in print
  • Post on a secure Intranet/Extranet website
  • Use in a PowerPoint Presentation
  • Distribute via CD-ROM
  • Photocopy

Click here to obtain permission for the above reuses.If you have questions or comments concerning the Rightslink service, please contact:

Rightslink Customer Care
Tel (toll free): 877/622-5543
Tel: 978/777-9929
E-mail: customercare@copyright.com
Web: http://www.rightslink.com

To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.

To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, pleaseclick here to view more information.

Loading stats for Advancing Nuclear Medicine Through Innovation...